K6 - Altered States, New Outcomes: Psychedelic Therapies for SUD

As the understanding of psychedelics grows, therapies involving substances like ibogaine, ketamine, and psilocybin are transforming the treatment of substance use disorders (SUD). This session will explore how these groundbreaking therapies are being used to address addiction by promoting neural plasticity, healing trauma, and offering new pathways for recovery.

Join our expert panel as they delve into the science behind psychedelic-assisted treatments, the clinical protocols involved, and the challenges of integrating these therapies into modern care. Panelists will also discuss patient experiences, ethical considerations, and the importance of supportive care structures for maximizing outcomes.

Whether you’re curious about the potential of psychedelics or already navigating this innovative space, this session will provide a comprehensive look at how altered states can unlock new possibilities for healing.